Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3771)
All Articles published online
|
Mar 1, 2004 (publication date) through Jul 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gumurdulu Y, Serin E, Özer B, Kayaselcuk F, Ozsahin K, Cosar AM, Gursoy M, Gur G, Yilmaz U, Boyacioglu S. Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. World J Gastroenterol 2004; 10(5): 668-671 [PMID: 14991935 DOI: 10.3748/wjg.v10.i5.668] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i5/668.htm |
| Number | Citing Articles |
| 1 |
Ferdane Sapmaz, Ismail Hakki Kalkan, Sefa Güliter, Pınar Atasoy. Comparison of Helicobacter pylori eradication rates of standard 14-day quadruple treatment and novel modified 10-day, 12-day and 14-day sequential treatments. European Journal of Internal Medicine 2014; 25(3): 224 doi: 10.1016/j.ejim.2013.11.006
|
| 2 |
Mesut Sezikli, Züleyha Akkan Çetinkaya, Fatih Güzelbulut, Atakan Yeşil, Mustafa Erhan Altınöz, Nuriye Ulu, Ayşe Oya Övünç Kurdaş. Efficacy of the Combination of Tetracycline, Amoxicillin, and Lansoprazole in the Eradication of Helicobacter pylori in Treatment-Naïve Patients and in Patients Who Are Not Responsive to Clarithromycin-Based Regimens: A Pilot Study. Gut and Liver 2012; 6(1): 41 doi: 10.5009/gnl.2012.6.1.41
|
| 3 |
Mojgan Jalalzadeh, Morteza Nazarian, Jamshid Vafaeimanesh, Fatemeh Mirzamohammadi. Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in hemodialysis Patients. Nephro-Urology Monthly 2012; 4(3): 571 doi: 10.5812/numonthly.2794
|
| 4 |
Ferdane Sapmaz, Ismail H Kalkan, Incilay Suslu, Hüseyin Demirci, Pinar Atasoy, Sefa Guliter. Lower plasma pantoprazole level predicts Helicobacter pylori treatment failure in patients with type 2 diabetes mellitus. Journal of Digestive Diseases 2015; 16(9): 531 doi: 10.1111/1751-2980.12272
|
| 5 |
Hong Cheng, Fu-Lian Hu. Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori. World Journal of Gastroenterology 2009; 15(7): 860-864 doi: 10.3748/wjg.15.860
|
| 6 |
Sergey I Pimanov, Elena V Makarenko, Alla V Voropaeva, Maya E Matveenko, Eugen V Voropaev. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. Journal of Gastroenterology and Hepatology 2008; 23(11): 1666 doi: 10.1111/j.1440-1746.2007.04983.x
|
| 7 |
Yuhong Yuan, Alex C Ford, Khurram J Khan, David Forman, Giuseppina Oderda, Xavier Calvet, Grigorios I Leontiadis, Carlo Fallone, Javier P Gisbert, Lori Fischbach, Franco Bazzoli, Paul Moayyedi, Yuhong Yuan. Cochrane Database of Systematic Reviews. 2010; doi: 10.1002/14651858.CD008337
|
| 8 |
Javier P Gisbert. “Rescue” regimens after <italic>Helicobacter pylori</italic> treatment failure. World Journal of Gastroenterology 2008; 14(35): 5385-5402 doi: 10.3748/wjg.14.5385
|
| 9 |
Jaime Natan Eisig, Tomás Navarro-Rodriguez, Ana Cristina Sá Teixeira, Fernando Marcuz Silva, Rejane Mattar, Decio Chinzon, Christiane Haro, Márcio Augusto Diniz, Joaquim Prado Moraes-Filho, Ronnie Fass, Ricardo Correa Barbuti. Standard Triple Therapy versus Sequential Therapy inHelicobacter pyloriEradication: A Double-Blind, Randomized, and Controlled Trial. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/818043
|
| 10 |
F. Iacopini, P. Crispino, O.A. Paoluzi, A. Consolazio, R. Pica, M. Rivera, D. Palladini, F. Nardi, P. Paoluzi. One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication. Digestive and Liver Disease 2005; 37(8): 571 doi: 10.1016/j.dld.2005.03.007
|
| 11 |
Feng‐Woei Tsay, Hui‐Hwa Tseng, Ping‐I Hsu, Kai‐Ming Wang, Ching‐Chang Lee, Shiuh‐Nan Chang, Huay‐Min Wang, Hsien‐Chung Yu, Wen‐Chi Chen, Nan‐Jing Peng, Kwok‐Hung Lai, Deng‐Chyang Wu. Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan. Journal of Gastroenterology and Hepatology 2012; 27(3): 498 doi: 10.1111/j.1440-1746.2011.06885.x
|
| 12 |
Mohammad Minakari, Amir Hosein Davarpanah Jazi, Ahmad Shavakhi, Neda Moghareabed, Farinaz Fatahi. A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second‐Line Therapy in Patients With Helicobacter pylori Infection. Helicobacter 2010; 15(2): 154 doi: 10.1111/j.1523-5378.2009.00739.x
|
| 13 |
Ping‐I Hsu, Wen‐Chi Chen, Feng‐Woei Tsay, Chih‐An Shih, Sung‐Shuo Kao, Huay‐Min Wang, Hsien‐Chung Yu, Kwok‐Hung Lai, Hui‐Hwa Tseng, Nan‐Jing Peng, Angela Chen, Chao‐Hung Kuo, Deng‐Chyang Wu. Ten‐Day Quadruple Therapy Comprising Proton‐Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin Achieves a High Eradication Rate for Helicobacter pylori Infection after Failure of Sequential Therapy. Helicobacter 2014; 19(1): 74 doi: 10.1111/hel.12085
|
| 14 |
Jiayin Ou, Jiayu Li, Yang Liu, Xiaohong Su, Wanchun Li, Xiaojun Zheng, Lang Zhang, Jing Chen, Huafeng Pan, Maher Abdelraheim Titi. Quality appraisal of clinical guidelines for Helicobacter pylori infection and systematic analysis of the level of evidence for recommendations. PLOS ONE 2024; 19(4): e0301006 doi: 10.1371/journal.pone.0301006
|
| 15 |
Ping-I Hsu, Feng-Woei Tsai, Sung-Shuo Kao, Wen-Hung Hsu, Jin-Shiung Cheng, Nan-Jing Peng, Kuo-Wang Tsai, Huang-Ming Hu, Yao-Kuang Wang, Seng-Kee Chuah, Angela Chen, Deng-Chyang Wu. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial. American Journal of Gastroenterology 2017; 112(9): 1374 doi: 10.1038/ajg.2017.195
|
| 16 |
Ping‐I Hsu, Feng‐Woei Tsay, John Y. Kao, Nan‐Jing Peng, Yan‐Hua Chen, Sheng‐Yeh Tang, Chao‐Hung Kuo, Sung‐Shuo Kao, Huay‐Min Wang, I‐Ting Wu, Chang‐Bih Shie, Seng‐Kee Chuah, Deng‐Chyang Wu. Tetracycline‐levofloxacin versus amoxicillin‐levofloxacin quadruple therapies in the second‐line treatment of Helicobacter pylori infection. Helicobacter 2021; 26(5) doi: 10.1111/hel.12840
|
| 17 |
Huseyin Alkim, Mustafa Iscan, Feriha Oz. Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey. Libyan Journal of Medicine 2011; 6(1): 8412 doi: 10.3402/ljm.v6i0.8412
|
| 18 |
Tural Safarov, Bukre Kiran, Melahat Bagirova, Adil M Allahverdiyev, Emrah Sefik Abamor. An overview of nanotechnology-based treatment approaches against Helicobacter Pylori. Expert Review of Anti-infective Therapy 2019; 17(10): 829 doi: 10.1080/14787210.2019.1677464
|
| 19 |
Tzung‐Shiun Wu, Huang‐Ming Hu, Fu‐Chen Kuo, Chao‐Hung Kuo. Eradication of Helicobacter pylori infection. The Kaohsiung Journal of Medical Sciences 2014; 30(4): 167 doi: 10.1016/j.kjms.2013.11.003
|
| 20 |
Chien-Lin Chen, I-Ting Wu, Deng-Chyang Wu, Wei-Yi Lei, Feng-Woei Tsay, Seng-Kee Chuah, Kuan-Yang Chen, Jyh-Chin Yang, Yu-Hwa Liu, Chao-Hung Kuo, Sz-Iuan Shiu, Chang-Bih Shie, Kuan-Hua Lin, Chia-Long Lee, Ping-I Hsu. Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection. Microorganisms 2023; 12(1): 6 doi: 10.3390/microorganisms12010006
|
| 21 |
Züleyha A. Çetinkaya, Mesut Sezikli, Fatih Güzelbulut, Süleyman Coşgun, Serkan Düzgün, Oya Ö. Kurdaş. Comparison of the Efficacy of the Two Tetracycline‐Containing Sequential Therapy Regimens for the Eradication of Helicobacter Pylori: 5 days Versus 14 days Amoxicillin. Helicobacter 2010; 15(2): 143 doi: 10.1111/j.1523-5378.2010.00747.x
|
| 22 |
M. Sezikli, Z. A. Çetinkaya, F. Güzelbulut, A. Yeşil, S. Coşgun, O. Ö. Kurdaş. Supplementing Vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori. Journal of Clinical Pharmacy and Therapeutics 2012; 37(3): 282 doi: 10.1111/j.1365-2710.2011.01286.x
|
| 23 |
Te-Fu Lin, Deng-Chyang Wu, Feng-Woei Tsay, Kuo-Wang Tsai, Tzung-Jiun Tsai, Nan-Jing Peng, Sung-Shuo Kao, Wen-Chi Chen, Yan-Hua Chen, Ping-I Hsu. Reverse hybrid therapy achieves a similar eradication rate as standard hybrid therapy for Helicobacter pylori infection. Journal of the Chinese Medical Association 2020; 83(3): 233 doi: 10.1097/JCMA.0000000000000256
|
| 24 |
Feng‐Woei Tsay, Deng‐Chyang Wu, Sung‐Shuo Kao, Tzung‐Jium Tsai, Kwok‐Hung Lai, Jin‐Shiung Cheng, Hoi‐Hung Chan, Huay‐Min Wang, Wei‐Lun Tsai, Hui‐Hwa Tseng, Nan‐Jin Peng, Ping‐I Hsu. Reverse Sequential Therapy Achieves a Similar Eradication Rate as Standard Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial. Helicobacter 2015; 20(1): 71 doi: 10.1111/hel.12176
|
| 25 |
Yuhong Yuan, Alex C Ford, Khurram J Khan, Javier P Gisbert, David Forman, Grigorios I Leontiadis, Frances Tse, Xavier Calvet, Carlo Fallone, Lori Fischbach, Giuseppina Oderda, Franco Bazzoli, Paul Moayyedi. Optimum duration of regimens forHelicobacter pylorieradication. Cochrane Database of Systematic Reviews 2013; doi: 10.1002/14651858.CD008337.pub2
|
| 26 |
Soohoon Kwon, Dong Ho Lee, Jae Bin Kang, Nayoung Kim, Young Soo Park, Cheol Min Shin, Hyuk Yoon, Yoon Jin Choi. The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure inHelicobacter pyloriEradication. The Korean Journal of Gastroenterology 2018; 71(4): 196 doi: 10.4166/kjg.2018.71.4.196
|
| 27 |
Chao-Hung Kuo, Fu-Chen Kuo, Huang-Ming Hu, Chung-Jung Liu, Sophie S. W. Wang, Yen-Hsu Chen, Ming-Chia Hsieh, Ming-Feng Hou, Deng-Chyang Wu. The Optimal First-Line Therapy ofHelicobacter pyloriInfection in Year 2012. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/168361
|
| 28 |
Ping-I Hsu, Deng-Chyang Wu, Wen-Chi Chen, Hui-Hwa Tseng, Hsien-Chung Yu, Huay-Min Wang, Sung-Shuo Kao, Kwok-Hung Lai, Angela Chen, Feng-Woei Tsay. Randomized Controlled Trial Comparing 7-Day Triple, 10-Day Sequential, and 7-Day Concomitant Therapies for Helicobacter pylori Infection. Antimicrobial Agents and Chemotherapy 2014; 58(10): 5936 doi: 10.1128/AAC.02922-14
|
| 29 |
Jian Zhang, Chuan Han, Wen Quan Lu, Na Wang, Si Ran Wu, Yong Xi Wang, Jin Ping Ma, Jie Hong Wang, Cheng Hao, Dong Hong Yuan, Na Liu, Yong Quan Shi. A randomized, multicenter and noninferiority study of amoxicillin plus berberine vs tetracycline plus furazolidone in quadruple therapy for Helicobacter pylori rescue treatment. Journal of Digestive Diseases 2020; 21(5): 256 doi: 10.1111/1751-2980.12870
|
| 30 |
Nazım EKİN, Berat EBİK, Ferhat BACAKSIZ. Helikobakter Pylori Birinci Basamak Tedavisi Alan Hastalarda Üç Farklı Tedavi Rejiminin Etkinliğinin Değerlendirilmesi. Harran Üniversitesi Tıp Fakültesi Dergisi 2021; 18(1): 100 doi: 10.35440/hutfd.822754
|
| 31 |
Mesut Sezikli, Züleyha Akkan Çetinkaya, Hayrünnisa Sezikli, Fatih Güzelbulut, Arzu Tiftikçi, Ali Tüzün İnce, Yasemin Gökden, Bülent Yaşar, Sacide Atalay, Oya Övünç Kurdaş. Oxidative Stress in Helicobacter pylori Infection: Does Supplementation with Vitamins C and E Increase the Eradication Rate?. Helicobacter 2009; 14(4): 280 doi: 10.1111/j.1523-5378.2009.00686.x
|
| 32 |
Javier P. Gisbert. Review: Second-line rescue therapy of Helicobacter pylori infection. Therapeutic Advances in Gastroenterology 2009; 2(6): 331 doi: 10.1177/1756283X09347109
|
| 33 |
Sung-Shuo Kao, Wen-Chi Chen, Ping-I Hsu, Kwok-Hung Lai, Hsien-Chung Yu, Hui-Hwa Cheng, Nan-Jing Peng, Chiun-Ku Lin, Hoi-Hung Chan, Wei-Lun Tsai, Huay-Min Wang, Tzung-Jiun Tsai, Kung-Hung Lin, Feng-Woei Tsay. 7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate forHelicobacter pyloriin Taiwan. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/463985
|
| 34 |
Saghi Riahizadeh, Reza Malekzadeh, Shahram Agah, Nasrin Zendehdel, Rasoul Sotoudehmanesh, Naser Ebrahimi‐Dariani, Akram Pourshams, Homayoon Vahedi, Javad Mikaeli, Morteza Khatibian, Sadegh Massarrat. Sequential Metronidazole‐Furazolidone or Clarithromycin‐Furazolidone Compared to Clarithromycin‐Based Quadruple Regimens for the Eradication of Helicobacter pylori in Peptic Ulcer Disease: A Double‐Blind Randomized Controlled Trial. Helicobacter 2010; 15(6): 497 doi: 10.1111/j.1523-5378.2010.00798.x
|
| 35 |
Maria José Temido, Dara Mbanze, Nuno Almeida, Bárbara Oliveiros, Elisa Gravito-Soares, Pedro Figueiredo. Is hybrid therapy more efficient in the eradication of Helicobacter pylori infection? A systematic review and meta-analysis. Annals of Clinical Microbiology and Antimicrobials 2023; 22(1) doi: 10.1186/s12941-023-00582-2
|
| 36 |
F. Perna, A. Zullo, C. Ricci, C. Hassan, S. Morini, D. Vaira. Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: Role of bacterial resistance. Digestive and Liver Disease 2007; 39(11): 1001 doi: 10.1016/j.dld.2007.06.016
|
| 37 |
Ferdane Sapmaz, Ismail H. Kalkan, Pinar Atasoy, Sebahat Basyigit, Sefa Guliter. A Non-Inferiority Study: Modified Dual Therapy Consisting Higher Doses of Rabeprazole Is as Successful as Standard Quadruple Therapy in Eradication of Helicobacter pylori. American Journal of Therapeutics 2017; 24(4): e393 doi: 10.1097/MJT.0000000000000316
|
| 38 |
Katsuhiko Tsukada, Hiroyuki Katoh, Tatsuya Miyazaki, Minoru Fukuchi, Hiroyuki Kuwano, Hitoshi Kimura, Yasuyuki Fukai, Takanori Inose, Teiji Motojima, Naotaka Toda, Shuji Yamada. Factors Associated with the Development of Reflux Esophagitis After Helicobacter pylori Eradication. Digestive Diseases and Sciences 2006; 51(3): 539 doi: 10.1007/s10620-006-3167-2
|
| 39 |
Abdurrahman Kadayifci, Hakan Buyukhatipoglu, M. Cemil Savas, Ilkay Simsek. Eradication of Helicobacter pylori with triple therapy:An epidemiologic analysis of trends in Turkey over 10 years. Clinical Therapeutics 2006; 28(11): 1960 doi: 10.1016/j.clinthera.2006.11.011
|
| 40 |
Haim Shmuely, Michael Friedman, Igor Aronov, Hanna Bernstine, Jacob Yahav, Zmira Samra, Gabriel Chodick, Craig S. Hamilton, Christian G. Samuelson, David Groshar. The effect of radioiodine on eradication of Helicobacter pylori infection in patients with thyroid cancer—A pilot study. Operative Techniques in Otolaryngology-Head and Neck Surgery 2012; 23(3): 206 doi: 10.1016/j.otot.2012.03.001
|
| 41 |
J. P. GISBERT, J.‐L. GISBERT, S. MARCOS, I. JIMENEZ‐ALONSO, R. MORENO‐OTERO, J. M. PAJARES. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10‐year single‐centre study of 500 patients. Alimentary Pharmacology & Therapeutics 2008; 27(4): 346 doi: 10.1111/j.1365-2036.2007.03573.x
|
| 42 |
J. P. GISBERT, M. FERNÁNDEZ‐BERMEJO, J. MOLINA‐INFANTE, B. PÉREZ‐GALLARDO, A.‐B. PRIETO‐BERMEJO, J.‐M. MATEOS‐RODRÍGUEZ, P. ROBLEDO‐ANDRÉS, G. GONZÁLEZ‐GARCÍA. First‐line triple therapy with levofloxacin for Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics 2007; 26(3): 495 doi: 10.1111/j.1365-2036.2007.03384.x
|
| 43 |
Pedro Cortés, Alfred D. Nelson, Yan Bi, Fernando F. Stancampiano, Loren P. Murray, George G.A. Pujalte, Victoria Gomez, Dana M. Harris. Treatment Approach of Refractory Helicobacter pylori Infection: A Comprehensive Review. Journal of Primary Care & Community Health 2021; 12: 215013272110140 doi: 10.1177/21501327211014087
|
| 44 |
Ping-I Hsu, Pei-Chin Lin, David Y Graham. Hybrid therapy for <italic>Helicobacter pylori</italic> infection: A systemic review and meta-analysis. World Journal of Gastroenterology 2015; 21(45): 12954-12962 doi: 10.3748/wjg.v21.i45.12954
|
| 45 |
Evren Abut, Bülent Yaşar, Hakan Güveli, Cengiz Bölükbaş, Filiz Füsun Bölükbaş, Ali Remzi Dalay, Oya Övünç Kurdaş. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study. Scandinavian Journal of Gastroenterology 2010; 45(6): 677 doi: 10.3109/00365521003702726
|
| 46 |
Evrim KAHRAMANOĞLU AKSOY, Muhammet Yener AKPINAR, Ferdane PİRİNÇÇİ SAPMAZ, Zeynep GÖKTAŞ, Gülçin Güler ŞİMŞEK, Metin UZMAN, Yaşar NAZLIGÜL. Prekanseröz lezyonların Helicobacter pylori eradikasyonuna olan etkisi. Akademik Gastroenteroloji Dergisi 2018; 17(3): 117 doi: 10.17941/agd.502358
|
| 47 |
Feng-Woei Tsay, Deng-Chyang Wu, Hsien-Chung Yu, Sung-Shuo Kao, Kung-Hung Lin, Jin-Shiung Cheng, Huay-Min Wang, Wen-Chi Chen, Wei-Chih Sun, Kuo-Wang Tsai, Ping-I Hsu. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. Antimicrobial Agents and Chemotherapy 2017; 61(11) doi: 10.1128/AAC.00140-17
|
| 48 |
David Y. Graham, Sun-Young Lee. How to Effectively Use Bismuth Quadruple Therapy. Gastroenterology Clinics of North America 2015; 44(3): 537 doi: 10.1016/j.gtc.2015.05.003
|
| 49 |
Angelo Zullo, Vincenzo De Francesco, Cesare Hassan, Carmine Panella, Sergio Morini, Enzo Ierardi. Second-line treatment for Helicobacter pylori eradication after sequential therapy failure: a pilot study. Therapy 2006; 3(2): 251 doi: 10.2217/14750708.3.2.251
|
| 50 |
Orhan Sezgin, Engin Altıntaş, Enver Üçbilek, Anıl Tombak, Burçin Tellioǧlu. Low Efficacy Rate of Moxifloxacin‐Containing Helicobacter pylori Eradication Treatment: In an Observational Study in a Turkish Population. Helicobacter 2007; 12(5): 518 doi: 10.1111/j.1523-5378.2007.00535.x
|
| 51 |
Huseyin Alkim, Ali Riza Koksal, Salih Boga, Ilker Sen, Canan Alkim. Role of Bismuth in the Eradication of Helicobacter pylori. American Journal of Therapeutics 2017; 24(6): e751 doi: 10.1097/MJT.0000000000000389
|
| 52 |
Ping-I Hsu, Sung-Shuo Kao, Deng-Chyang Wu, Wen-Chi Chen, Nan-Jing Peng, Hsien-Chung Yu, Huay-Min Wang, Kwok-Hung Lai, Jin-Shiung Cheng, Angela Chen, Seng-Kee Chuah, Feng-Woei Tsay. A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection. Medicine 2015; 94(48): e2104 doi: 10.1097/MD.0000000000002104
|
| 53 |
Rajmohan Rammohan, Sai Greeshma Magam, Melvin Joy, Dilman Natt, Achal Patel, Abhishek Tadikonda, Jiten Desai, Susan Bunting , Robert M Yost , Olawale Akande, Paul Mustacchia. Unpacking the Racial Gap: Helicobacter pylori Infection Clearance Among Different Racial Groups. Cureus 2023; doi: 10.7759/cureus.43080
|
| 54 |
Ismail Hakki Kalkan, Ferdane Sapmaz, Sefa Güliter, Pınar Atasoy. Severe gastritis decreases success rate of Helicobacter pylori eradication. Wiener klinische Wochenschrift 2016; 128(9-10): 329 doi: 10.1007/s00508-015-0896-2
|
| 55 |
Jacqueline A. Hart, Richard Glickman-Simon. Phytomedicines for Helicobacter pylori, Garlic for Hypertension, Intraoperative Acupuncture for Tonsillectomy, Omega-3 Fatty Acids for Cognitive Decline, Qigong for COPD. EXPLORE 2016; 12(2): 141 doi: 10.1016/j.explore.2015.12.011
|
| 56 |
Sintayehu Fekadu, Hizkel Engiso, Sisay Seyfe, Hisashi Iizasa, Ashebir Godebo, Serawit Deyno, Hironori Yoshiyama. Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02707-5
|
| 57 |
Ahmad Alfadhli, Mohamed Alboraie, Mostafa Afifi, Abhijit Dangi. A randomized clinical trial comparing triple therapy versus non-bismuth based quadruple therapy for the eradication of Helicobacter Pylori in Kuwait. Journal of Global Infectious Diseases 2022; 14(3): 99 doi: 10.4103/jgid.jgid_13_22
|
| 58 |
Metin Küçükazman, Ayse Kefeli, Sebahat Basyigit, Abdullah Özgür Yeniova, Yasar Nazligül, Ibrahim Halil Akkus, Ayla Tezer, Servet Guresci. Efficacy of Bismuth-Containing Quadruple Therapy as
First-line Treatment for Helicobacter pylori Infection. Euroasian Journal of Hepato-Gastroenterology 2012; 2(2): 90 doi: 10.5005/jp-journals-10018-1041
|
| 59 |
Morris O. Makobongo, Hanan Gancz, Beth M. Carpenter, Dennis P. McDaniel, D. Scott Merrell.
The Oligo-Acyl Lysyl Antimicrobial Peptide C
12
K-2β
12
Exhibits a Dual Mechanism of Action and Demonstrates Strong
In Vivo
Efficacy against Helicobacter pylori
. Antimicrobial Agents and Chemotherapy 2012; 56(1): 378 doi: 10.1128/AAC.00689-11
|
| 60 |
Hyun Chul Lim, Yong Jae Lee, Byoungrak An, Seung Woo Lee, Yong Chan Lee, Byung Soo Moon. Rifabutin‐based High‐dose Proton‐pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment for Helicobacter pylori. Helicobacter 2014; 19(6): 455 doi: 10.1111/hel.12147
|
| 61 |
Ahmet Burak Toros, Ali Tüzün İnce, Besir Kesici, Mustafa Saglam, Zulfikar Polat, Ahmet Uygun. A New Modified Concomitant Therapy for Helicobacter pylori Eradication in Turkey. Helicobacter 2011; 16(3): 225 doi: 10.1111/j.1523-5378.2011.00823.x
|
| 62 |
Marwa S. Fathi, Runia Fouad EL-Folly, Rania Ahmed Hassan, Mohammed Ezz El-Arab. Genotypic and phenotypic patterns of antimicrobial susceptibility of Helicobacter pylori strains among Egyptian patients. Egyptian Journal of Medical Human Genetics 2013; 14(3): 235 doi: 10.1016/j.ejmhg.2013.03.004
|
| 63 |
Chong-Hou Lok, Dong Zhu, Jia Wang, Yu-Tang Ren, Xuan Jiang, Shu-Jun Li, Xiu-Ying Zhao. <p>Phenotype and Molecular Detection of Clarithromycin and Levofloxacin Resistance in <em>Helicobacter pylori</em> Clinical Isolates in Beijing</p>. Infection and Drug Resistance 2020; : 2145 doi: 10.2147/IDR.S249370
|
| 64 |
Orhan Sezgin, Engin Altınta5, Erdinç Nayır, Enver Üçbilek. A Pilot Study Evaluating Sequential Administration of a PPI–Amoxicillin Followed by a PPI–Metronidazole–Tetracycline in Turkey. Helicobacter 2007; 12(6): 629 doi: 10.1111/j.1523-5378.2007.00547.x
|
| 65 |
A. Zullo, V. De Francesco, G. Scaccianoce, G. Manes, C. Efrati, C. Hassan, G. Maconi, D. Piglionica, C. Cannaviello, C. Panella, S. Morini, E. Ierardi. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: A multicentre study. Digestive and Liver Disease 2007; 39(9): 806 doi: 10.1016/j.dld.2007.05.021
|
| 66 |
Hafez Fakheri, Zohreh Bari, Mohsen Aarabi, Reza Malekzadeh. <italic>Helicobacter pylori</italic> eradication in West Asia: A review. World Journal of Gastroenterology 2014; 20(30): 10355-10367 doi: 10.3748/wjg.v20.i30.10355
|
| 67 |
Ya-Nan Gong, You-Ming Li, Ning-Min Yang, Hong-Zhang Li, Feng Guo, Lang Lin, Qun-Ying Wang, Jia-Kun Zhang, Zi-Zhong Ji, Ji-Bo Mao, Jun-Liang Mao, Zheng-Chao Shi, Wu-Heng Tang, Xin-Jian Zhu, Wei Shao, Xiao-Feng Zhang, Xing-Hua Wang, Yue-Feng Tong, Mi-Zu Jiang, Guang-Lan Chen, Zhi-Yong Wang, Hui-Min Tu, Guo-Fa Jiang, Jian-Sheng Wu, Xu-Peng Chen, Qiu-Long Ding, Hong Ouyang, Feng-Zhe Jin, Yan-Li Xu, Jian-Zhong Zhang. Centralized isolation of <italic>Helicobacter pylori</italic> from multiple centers and transport condition influences. World Journal of Gastroenterology 2015; 21(3): 944-952 doi: 10.3748/wjg.v21.i3.944
|
| 68 |
Angelo Zullo, Vincenzo De Francesco, Cesare Hassan, Carmine Panella, Sergio Morini, Enzo Ierardi. Second-line treatment for Helicobacter pylori eradication after sequential therapy failure: a pilot study. Therapy 2006; 3(2): 251 doi: 10.2217/14750708.3.2.251
|
| 69 |
Dino Vaira, Angelo Zullo, Cesare Hassan, Giulia Fiorini, Nimish Vakil. Sequential therapy for Helicobacter pylori eradication: the time is now!. Therapeutic Advances in Gastroenterology 2009; 2(6): 317 doi: 10.1177/1756283X09343326
|
| 70 |
Shahrokh Mousavi, Jafar Toussy, Siamak Yaghmaie, Mehrdad Zahmatkesh. Azithromycin in one week quadruple therapy for <italic>H pylori</italic> eradication in Iran. World Journal of Gastroenterology 2006; 12(28): 4553-4556 doi: 10.3748/wjg.v12.i28.4553
|
| 71 |
Kevin S H Liu, Ivan F N Hung, W K Walter Seto, Teresa Tong, Axel S J Hsu, Frank Y F Lam, David Y K But, S Y Wong, Wai K Leung. Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment forHelicobacter pyloriin Chinese patients: an open label, randomised, crossover trial. Gut 2014; 63(9): 1410 doi: 10.1136/gutjnl-2013-306120
|
| 72 |
Yildiran Songür, Altuğ Şenol, Ayşe Balkarli, Abdülkadir Baştürk, Süreyya Çerçi. Triple or Quadruple Tetracycline-Based Therapies Versus Standard Triple Treatment for Helicobacter pylori Treatment. The American Journal of the Medical Sciences 2009; 338(1): 50 doi: 10.1097/MAJ.0b013e31819c7320
|
| 73 |
Jihee Sung, Nayoung Kim, Yo Han Park, Young Jae Hwang, Soohoon Kwon, Gyeongjae Na, Joon Young Choi, Jae Bin Kang, Hye Rang Kim, Jin-Wook Kim, Dong Ho Lee. Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with forHelicobacter pyloriEradication Failure. The Korean Journal of Gastroenterology 2017; 69(2): 109 doi: 10.4166/kjg.2017.69.2.109
|
| 74 |
Soohoon Kwon, Dong Ho Lee, Jae Bin Kang, Nayoung Kim, Young Soo Park, Cheol Min Shin, Hyuk Yoon, Yoon Jin Choi. The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure inHelicobacter pyloriEradication. The Korean Journal of Gastroenterology 2017; 70(2): 72 doi: 10.4166/kjg.2017.70.2.72
|
| 75 |
Majid Darraj. Eradication Rate and Factors Influencing Helicobacter pylori Infection Clearance Using Standard Triple Therapy at a Single Centre in Jazan Region, Saudi Arabia: A Retrospective Study. International Journal of General Medicine 2024; : 2627 doi: 10.2147/IJGM.S456865
|
| 76 |
Chih-Chieh Huang, Kuo-Wang Tsai, Tzung-Jiun Tsai, Ping-I Hsu. Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy. Biomarker Research 2017; 5(1) doi: 10.1186/s40364-017-0103-x
|